{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 443977985
| IUPAC_name = 3,6-diamino-''N''-[(3''R'',6''Z'')-3-(2-amino-3,4,5,6-tetrahydropyrimidin-4-yl)-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide
| image = Enviomycin.svg

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|enviomycin}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Rx-only
| routes_of_administration = IM

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 33103-22-9
| ATC_prefix = none
| ATC_suffix =  
| ATC_supplemental =  
| PubChem = 3032903
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB08993
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = XU299C23A2
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07897
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2146142
|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 16736480
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C25H43N13O10/c26-3-1-16(41)10(27)5-17(42)33-12-6-31-23(47)18(11-2-4-30-24(28)37-11)38-20(44)13(7-32-25(29)48)34-21(45)14(8-39)36-22(46)15(9-40)35-19(12)43/h7,10-12,14-16,18,39-41H,1-6,8-9,26-27H2,(H,31,47)(H,33,42)(H,34,45)(H,35,43)(H,36,46)(H,38,44)(H3,28,30,37)(H3,29,32,48)/b13-7-/t10-,11-,12+,14+,15+,16-,18+/m1/s1
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = HPWIIERXAFODPP-GHBBWTPBSA-N

<!--Chemical data-->
| chemical_formula =  
| C=25 | H=43 | N=13 | O=10 
| molecular_weight = 685.69 g/mol
| smiles = C1CN=C(NC1C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CO)CO)NC(=O)CC(C(CCN)O)N)N
}}

'''Enviomycin''' ([[International Nonproprietary Name|INN]], also called '''tuberactinomycin N''') is an [[antibiotic]] drug, isolated from ''[[Streptomyces griseoverticillatus]]'' var. ''tuberacticus''.<ref>[http://www.google.com/patents?id=FWMvAAAAEBAJ&dq=3892732 Jinnosuke Abe et al. Antibiotic Tuberactinomycin-N and process for production thereof. US patent 3892732]</ref> It is used in the treatment of [[tuberculosis]].<ref>{{cite journal | last1 = Selvakumar | first1 = N | last2 = Kumar | first2 = V | last3 = Acharyulu | first3 = GS | last4 = Rehman | first4 = F | last5 = Paramasivan | first5 = CN | last6 = Prabhakar | first6 = R | title = Susceptibility of south Indian strains of Mycobacterium tuberculosis to tuberactinomycin | journal = The Indian journal of medical research | volume = 95 | pages = 101â€“4 | year = 1992 | pmid = 1506058 }}</ref> 

==References==
<references/>

[[Category:Polypeptide antibiotics]]


{{antiinfective-drug-stub}}